ภาวะขาดธาตุเหล็กในผู้บริจาคโลหิต: อาการ การวินิจฉัย และการรักษาเบื้องต้น
Keywords:
-Abstract
-
Downloads
References
Gammon R, ed. Standards for blood banks and transfusion services. 33rd ed. Bethesda, MD: AABB; 2022.
Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, et al. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2011;51:511-22.
Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, et al. Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2012;52:702-11.
Reddy KV, Shastry S, Raturi M, Baliga BP. Impact of regular whole-blood donation on body iron stores. Transfus Med Hemother. 2020;47:75-9.
AABB Donor Iron Deficiency Risk-Based Decision-Making Assessment Report. Report of the Ad hoc iron-deficiency working group. In: Ooley P, editor. Standards for blood banks and transfusion services. 30th ed. Bethesda, MD: American Asssociation of Blood Banks; 2016.
Pratt JJ, Khan KS. Non-anaemic iron deficiency - a disease looking for recognition of diagnosis: A systematic review. Eur J Haematol. 2015;96:618-28.
Sohrabi F. Tip of the iceberg: extra-haematological consequences of early iron deficiency. J Glob Health. 2015;5:020304. doi: 10.7189/
jogh.05.020304.
American Association of Blood Banks. Updated strategies to limit or prevent iron deficiency in blood donors. AABB Association
Bulletin #17-02. Bethesda, MD: AABB; 2017. Updated 2022.
Thimthong N, Photi-a A, Traivaree C, Apipongrat D, Nathalang O. Diagnosis of iron deficiency anemia in Thai female adolescents
using reticulocyte hemoglobin equivalent. J Southeast Asian Med Res. 2022;6:e0126. https://doi.org/10.55374/jseamed.v6i0.126.
Li H, Condon F, Kessler D, Nandi V, Rebosa M, Westerman M, et al. Evidence or relative iron deficiency in platelet- and plasma-
pheresis donors correlates with donation frequency. J Clin Apher. 2016;31:551-8.
Page EA, Coppock JE, Harrison JF. Study of iron stores in regular plateletpheresis donors. Transfus Med. 2010;20:22-9.
Bravo MD, Custer B, Tomasulo PA, Kamel H. Age and gender relationships observed in routine ferritin testing (abstract). Transfusion. 2014;54(2S):116A-7A.
Kiss JE, Brambilla D, Glynn SA, Mast AE, Spencer BR, Stone M, et al. Oral iron supplementation after blood donation: A randomized
clinical trial. JAMA. 2015;313:575-83.
Mast AE, Bialkowski W, Bryant BJ, Wright DJ, Birch R, Kiss JE, et al. A randomized, blinded, placebo-controlled trial of education
and iron supplementation for mitigation of iron deficiency in regular blood donors. Transfusion. 2016;56:1588-97.
Schotten N, Pasker-de Jong PCM, Moretti D, Zimmermann MB, Geurts-Moespot A, Swinkels DW, et al. The donation interval of
days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism. Blood. 2016;128:2185-8.
Goldman M, Magnussen K, Gorlin J, Lozano M, Speedy J, Keller A, et al. International forum regarding practices related to donor
haemoglobin and iron. Vox Sang. 2016;111:449-55.
Goldman M, Uzicanin S, Scalia J, Scalia V, O’Brien SF. Impact of informing donors of low ferritin results. Transfusion. 2016;56:2193-
Sayers M, Centilli J. Contemplating the effect on blood availability if the interdonation interval of 56 days is prolonged. Transfusion.
;53:1132-6.
Spencer BR, Johnson B, Wright DJ, Kleinman S, Glynn SA, Cable RG, et al. Potential impact on blood availability and donor iron
status of changes to donor hemoglobin cutoff and interdonation intervals. Transfusion. 2016;56:1994-2004.
Domen RE. Drugs and donors: ethical considerations in the use of hematopoietic enhancing agents in volunteer whole blood and
blood component donors. In: Domen RE, editor. Ethical issues in transfusion medicine and cellular therapies. Bethesda, MD: AABB Press; 2015. p. 99-108.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Journal of Hematology and Transfusion Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
